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Am J Med Genet Part A 173A:268–273.Small supernumerary marker chromosomes (sSMC) are abnor-
mal chromosomes that cannot be characterized by standard
banding cytogenetic techniques. A minority of sSMC contain
a neocentromere, which is an ectopic centromere lacking the
characteristic alpha-satellite DNA. The phenotypic manifesta-
tions of sSMC and neocentromeric sSMC are variable and range
from severe intellectual disability and multiple congenital
anomalies to a normal phenotype. Here we report a patient
with a diagnosis of Marfan syndrome and infertility found to
have an abnormal karyotype consisting of a chromosome 15
deletion and a ring-type sSMC likely stabilized by a neocentro-
mere derived via a mechanism initially described by Barbara
McClintock in 1938. Analysis of the sSMC identified that it
contained the deleted chromosome 15 material and also one
copy of FBN1, the gene responsible for Marfan syndrome. We
propose that the patient’s diagnosis arose from disruption of the
FBN1 allele on the sSMC. To date, a total of 29 patients have been
reported with an sSMC derived from a chromosomal deletion.
We review these cases with a specific focus on the resultant
phenotypes and note significant difference between this class of
sSMC and other types of sSMC. Through this review we also
identified a patient with a clinical diagnosis of neurofibromato-
sis type 1 who lacked a family history of the condition but was
found to have a chromosome 17-derived sSMC that likely con-
tainedNF1 and caused the patient’s disorder.We also review the
genetic counseling implications and recommendations for a
patient or family harboring an sSMC.  2016 Wiley Periodicals, Inc.
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Small supernumerary marker chromosomes (sSMC) are structur-
ally abnormal chromosomes that cannot be identified or charac-
terized unambiguously by conventional banding cytogenetic
techniques [Liehr and Weise, 2007]. sSMC are estimated to occur2016 Wiley Periodicals, Inc.in 3 out of every 10,000 births and have variable phenotypic
consequences depending on the genomic regions involved [Liehr
andWeise, 2007]. Phenotypes can range from retained fertility and
normal intellect to severe intellectual disability and multiple con-
genital anomalies [Liehr and Weise, 2007]. sSMCmost commonly
arise from acrocentric chromosomes with approximately 40% of
known sSMC involving chromosome 15 [Liehr, 2016]. A minority
of reported sSMC are those containing a neocentrome, which is an
ectopic centromere that lacks typically characteristic alpha-satellite
DNA and rescues an acentric chromosomal fragment [Marshall
et al., 2008]. Neocentromeres bind all known essential centromere
proteins and therefore behave like normal centromeres in mitosis
and meiosis [Marshall et al., 2008].
Initially discovered in 1993, neocentromeres are most com-
monly found on inverted duplicatedmarker chromosomes causing
an individual to be tetrasomic for the region of duplication or
trisomic if the sSMC is accompanied by a deleted chromosomal
complement [Voullaire et al., 1993; Marshall et al., 2008]. Their
formation is not completely understood though it has been sug-
gested theymay arise from aberrant CENP-A incorporation and/or
a chromosomal rearrangement that induces an epigenetic change268
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approximately 14% of neocentromere cases, the neocentromere is
associated with a chromosomal deletion and the subsequent for-
mation of a ring chromosome containing the deleted chromosomal
material and a neocentromere, resulting in an apparently balanced
karyotype [Marshall et al., 2008]. Barbara McClintock initially
described the suspected mechanism for the formation of this type
of karyotype in 1938 through the study of maize [McClintock,
1938]. She proposed their formation through centromere misdi-
vision when one chromosomal break occurs within one chromo-
some’s centromeric alpha-satellite DNA and a second break occurs
in one armof the chromosome. This results in two centromeres and
an apparently balanced karyotype with a partially deleted chromo-
some and a complementary ring chromosome [McClintock, 1938].
Marfan syndrome (MS; OMIM #154700) is a well described
autosomal dominant connective tissue disorder whose major clini-
cal features include disproportionate long bone overgrowth, aortic
root aneurysms, and ectopia lentis [Loeys et al., 2010]. Based on the
revisedGhent nosology, the diagnosis ofMS relies on a combination
of clinical features andmolecular testingbut canbemade exclusively
on clinical grounds [Loeys et al., 2010]. In 1991 FBN1, located at
15q21.1 and encoding for fibrillin-1, was identified as the gene
responsible forMarfan syndrome [Dietz et al., 1991]. Subsequently,
multiple types of pathogenic variants have been identified with
disease caused by suspected dominant-negative activity but with
haploinsufficency also contributing to disease [Dietz et al., 1993;
Eldadah et al., 1995; Judge et al., 2004; Faivre et al., 2007].
Here, we describe the clinical presentation, diagnosis, and
cytogenetic workup of an infertile adult male with Marfan
syndrome found to have a ring-type sSMC containing both a
neocentromere and chromosomal material derived from an
interstitial deletion of chromosome 15. A review of the pheno-
type and karyotype of all postnatal patients reported with sSMC
derived from the suspected McClintock-mechanism was also
performed.RESULTS
Patient Description
The 34-year-old male patient was referred to the University of
MichiganMedical Genetics Clinic for counseling after an abnormal
chromosomal constitution was identified on a peripheral blood
karyotype. He was clinically diagnosed with Marfan syndrome at
age 14. His medical history consisted of aortic root dilation of
4.7 cm (Z-score: 5.28) and mitral valve prolapse with moderate-
severe mitral regurgitation. These abnormalities were previously
corrected surgically at 26 years of age via valve-sparing aortic root
surgery with mitral valve repair. Additional medical complications
included a history of pectus excavatum that was surgically cor-
rected at 5 years of age and the subsequent development of pectus
carinatum. The patient also had a history of myopia but with no
ectopia lentis. His family historywas negative forMarfan syndrome
and for similar features. All of the patient’s siblings reportedly had
normal echocardiograms.
On physical examination his upper segment to lower segment
ratio and arm span to height ratio were 0.93 and 0.99,respectively (normal for mixed European ancestry). His head
was normally shaped with level palpebral fissures and no
enophthalmos. He exhibited malar hypoplasia but with no
retrognathia. No ectopia lentis was visible in the office; glasses
were worn for myopia. He reported having a normal dilated
ophthalmology exam 1 to 2 years prior and planned to be seen
for follow-up. He had arachnodactyly and a positive wrist and
thumb sign. A sternotomy scar, a loud systolic murmur and
pectus carinatum were also present. Review of his physical
examination and past history provided a systemic score of 8
[wrist and thumb sign (3), pectus carinatum (2), pectus exca-
vatum (1), myopia (1), and mitral valve prolapse (1) and a
Beighton score of 3/9 with hypermobile bilateral fifth fingers
and right knee]. Pertinent negative findings included an absence
of the following findings: bifid uvula, cleft palate, hypertelorism,
clubfoot, craniosynostosis, abnormal skin, joint abnormalities,
joint hypermobility (Beighton score of 3/9), and levido retic-
ularis. Based on his aortic root size (Z-score: 5.28) and his
systemic score >7, his clinical diagnosis of Marfan syndrome
was confirmed during his clinic visit.
As a result of failure to conceive, a fertility workup revealed the
presence of azoospermia in the patient. A peripheral blood karyotype
was performed and showed a non-mosaic abnormal chromosomal
constitution; 47,XY,del(15)(q11.1q21.1),þr(15)(q11.1q21.1) (Fig. 1).
Metaphase FISH analysis showed that the sSMC hybridized with a
probe that targets 15q11.2 while the chromosome 15 harboring a
deletion lacked a hybridization signal. The sSMC showed no hybrid-
ization with a probe that targets the alpha-satellite DNA of chromo-
some 15, suggesting the presence of a neocentromere. Additionally, a
probe that hybridizes to 15q12.1 within the FBN1 gene was used and
showed two signals, oneon thenormal chromosome15andoneon the
sSMC.Thekaryotype included a combinationof an interstitial deletion
ofchromosome15andansSMCcomposedof thedeletedchromosome
15 material. Alternatively, a very small amount of alphoid DNA may
havebeenpresentbut failed tohybridizewith the alpha-satellite specific
FISH probe.
The patient was provided with genetic counseling regarding
his karyotypic abnormalities in the setting of his azoospermia and
Marfan syndrome (see discussion section for additional general
information provided about reproductive outcomes). He was
counseled that given the diagnosis of Marfan syndrome and a
chromosome 15 abnormality that encompasses the FBN1 gene,
our suspicion is that the FBN1 Locus on the ring chromosome is
in some way disrupted. Possible explanations provided included:
(i) the translocation has specifically occurred within the FBN1
gene, thereby disrupting that specific copy; (ii) the FBN1 gene
though intact, is expressed at a decreased level as a result of the
ring formation; (iii) a specific segment of FBN1 has been deleted
due to the translocation, and resulted in a nonfunctional copy
and; (iv) the unlikely possibility that a point mutation in one of
the two intact genes could cause a loss-of-function, causing
Marfan syndrome.
The patient was counseled that as best we can tell, his deletion and
subsequent ring formation is balanced, therefore not leaving him
haploinsufficient for a number of genes, but presumably has resulted
in his havingMarfan syndrome and azoospermia. To further charac-
terize his clinical diagnosis of Marfan syndrome and his cytogenetic
FIG. 1. Cytogenetic results. A: Peripheral karyotype denoted as 47,XY,del(15)(q11.1q21.1),þr(15)(q11.1q21.1). The arrows are pointing out the
abnormal chromosome 15 and the SMC. B: Metaphase FISH analysis showing normal hybridization of the normal chromosome 15 with a centromeric
chromosome 15 probe (CEP15) and a probe that hybridizes with 15q26.1 (RP11-24J19). The SMC lacks hybridization with the centromeric
chromosome 15 probe suggesting the presence of a neocentromere given the SMC material is derived from chromosome 15. C: Metaphase FISH
analysis showing at least part of the FBN1 gene from the partially deleted chromosome 15 is on the SMC. The green RP11-475F15 probe
(BlueGnome, UK) hybridizes to 15q21.1 (chr15:48,772,344-48,869,180; hg19) within the FBN1 gene. D: Ideogram of both copies of the patient’s
chromosome 15 and the SMC with the suspected location of the FBN1 gene denoted. [Color figure can be viewed at wileyonlinelibrary.com].
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and chromosome microarray analysis was offered but declined by
the patient.DISCUSSION
To our knowledge, the patient presented here represents the first
and only case of an interstitial deletion of chromosome 15 with a
resultant ring-type sSMC stabilized by a neocentromere. The
patient also carries a clinical diagnosis of Marfan syndrome based
on the presence of a dilated aortic root and a positive systemic
score. Interestingly, the ring chromosome was formed from a
deletion on chromosome 15 with a distal breakpoint at approxi-
mately 15q21.1, the same chromosomal band where FBN1 Lies.
Further, FISH analysis showed that at least part of FBN1was on the
sSMC. While further workup was not possible due to patient
preference, it is likely that the FBN1 allele on the ring chromosome
was disrupted and therefore caused the patient’sMarfan syndrome.
FBN1 sequencing and/or FNB1 deletion/duplication testing would
have provided necessary additional information to further support
or disprove this hypothesis. As there is considerable phenotypic
overlap with Loeys–Dietz syndrome,molecular testing of TGFBR1,TGFBR2, SMAD3, andTGFB2would have been considered if FBN1
testing was normal.
Of all sSMC, ring types represent approximately 10%, while
sSMC containing neocentromeres account for only 2% [Marshall
et al., 2008; Liehr, 2016]. Those ring-type sSMC that contain
genomicmaterial derived from a chromosomal interstitial deletion
and harboring a neocentromere are exceedingly rare [Baldwin
et al., 2008; Liehr, 2016].
A total of 29 postnatal patients have been reportedwith an sSMC
derived by the suspected McClintock mechanism that yielded an
apparently balanced karyotype (Table I). Review of these patients
reveals a highly variable phenotype that includes normal individu-
als with retained fertility, patients with isolated infertility, and
patients with multiple congenital anomalies and severe intellectual
disability. Our patient presented with infertility in the form of
azoospermia. Fertility problems are a known complication of
chromosomal aberrations with the presence of an sSMC enhanced
in infertile groups when compared to the normal population;
0.125% and 0.044%, respectively [Liehr and Weise, 2007].
There have been conflicting reports regarding the gender-specific
rates of infertility in sSMC carriers, with initial results suggesting a
male to female ratio of 7.5:1, though more recent studies have
TABLE I. Previously Reported Postnatal Patients Who Presented With a Supernumerary Marker Chromosome That Developed by the
Suspected McClintock Mechanism
Case Age/Sex Karyotype Mosaic Neocentromere Phenotype Infertility
1a 34/M 47,XY,del(15)(q11.1!q21.1),+r(15)(q11.1!q21.1) N Y Marfan
syndrome
Y
2b 17/M 47,XY,del(4)(q21.1 ! q21.3),+r(4)(q21.1 ! q21.3) Y Y ID, hyper-IgE
syndrome
?








5e ?/F 47,XY,del(2)(q22 ! q32.2),+r(2)(q22 ! q32.2) Y ? ID ?
6f 23/F 47,XX,del(3)(p21.3 ! q25),+r(3)(p21.3 ! q25) N Y ID ?
7g Adult/F 47,XX,del(4)(p12 ! q10),+r(4)(p12 ! q10) Y N External ear
anomalies
N
8h 82/F 47,XX,del(17)(pter!cen::q11.2 or q12!qter),+r(17)
(cen!q11.2 or q12)
Y N NF1 N
9i 19/F 47,XX,del(9)(pter ! cen::q32 ! qter),+r(9)(cen ! q32) Y N ID ?




11k 1/F 47,X,del(X)(pter ! q21.1::p21 ! pter),+r(X)(p21 ! q11  12) Y N ID, MCA ?
12l 34/F 47,XX,del(11)(p11.1!p15.1),+r(11)(11p11.1!p15.1) Y N Aniridia N
13m 26/M 47,XY,del(3)(p11 ! q11),+r(3)(p11 ! q11) N Y Normal N
14n Adult/F 47,XX,del(6)(p11.2  p11.1 ! q12),+r(6)(p11.2  p11.1 !
q12)
Y N Normal N
15o 41/F 47,XX,del(6)(q11 ! q13),+r(6)(q11 ! q13) Y N Normal N
16p Adult/F 47,XX,del(11)(p11.12!p11.2),+r(11)(p11.12!p11.2) Y Y Normal N
17q Adult/F 47,XX,del(12)(p13.1!q10),+r(12)(p13.1!q10) N ? ? N
18r 32/F 47,XX,del(13)(pter ! q21.32:: q22.2 ! qter),+r(13)(q21.32 !
q22.2)
N Y Normal N; 3
miscarriages‡
19s 26/F 47,XX,del(17)(pter!p11.2::cen!qter) + r(17)(p11.2!cen) Y ? Normal N
20t 21/F 47,XX,del(19)(q11.05!q13.2),+r(19)(q11.05!q13.2) N N Normal N
21u 44/F 47,XX,del(22)(q11.1!q11.2),r(22)(q11.1!q11.2) Y N Normal N
22v Adult/F 47,XX,del(22)(q10 ! q11.2) + r(22)(q10 ! q11.2) N N Normal N
23w Adult/M 47,XY,del(6)(p22.3 ! q10),+r(6)(p22.3 ! q10) N ? Normal Y
24x Adult/M 46,XY,t(4;15)(p12;q26.2), del(6)(q16.2! q22.2),+r(6)(q16.2!
q22.2)
N Y Normal N
25y Adult/M 47,XY,del(8)(p11.1 ! q12.1),+r(8)(p11.1 ! q12.1) Y Y Normal N
26z 38/M 47,Y,t(X;4)(q23;q13),del(1)(p32 ! p36.1) + r(1)(p32 ! p36.1) Y Y Normal Y
27aa 29/M 47,XY,del(13)(pter!q12.3::q22!qter),+r(13)(q12.3!q22) Y Y Normal Y
28bb Adult/M 47,XY,del(2)(p12 ! p11.1),+r(2)(p12 ! p11.1) N N Normal N
ID, Intellectual disability; M, Male; F, Female; Y, Yes; N, No; MCA, Multiple congenital anomalies; NF1, Neurofibromatosis type 1.
‡The patient eventually experienced a normal pregnancy. aPresent case; bGrimbacher et al. [1999]; cAmor et al. [2005]; dPetit and Fryns. [1997]; eNasiri et al. [2007]; fMaraschio et al. [1996]; gBaldwin
et al. [2008]; hAndersen et al. [1990]; iPfeiffer et al. [1990]; jKrauss et al. [1987]; kStavropoulou et al. [1998]; lMannens et al. [1991]; mWandall et al. [1998]; nLiehr et al. [2013]; oVlckova et al. [2012];
pChuang et al. [2005]; qDonlon et al. [1992]; rKnegt et al. [2003]; sFriedman and Harrod. [1992]; tQuack et al. [1991]; uToutain et al. [2011]; vReynolds et al. [2004]; wManvelyan et al. [2008]; xQin et al.
[2007]; yBurnside et al. [2009]; zSlater et al. [1999]; aaCui et al. [2011]; bbLasan Trcic et al. [2003].
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[Liehr andWeise, 2007;Manvelyan et al., 2008; Liehr, 2014]. Review
of Table I also supports a male predisposition towards infertility
compared to females as only males have been reported with infertil-
ity in this cohort. It should be noted though that one female patient
experienced three miscarriages, but eventually went on to have a
normal pregnancy [Knegt et al., 2003]. Table I clearly represents a
biased sampling asmales represent only 34%(10/29) of the reported
patients while females represent 66% (19/29). As somepatientswereascertained through parental testing following the diagnosis of a
child harboring an unbalanced chromosomal constitution, this
falsely produces an elevatedpercentage of fertile females as infertility
affects males more often. It has additionally been shown that male
carriers of an sSMC derived from an acrocentric chromosome
are more likely to present with impaired spermatogenesis, as was
the case in our patient [Liehr, 2014]. Detailed sperm analysis of
infertile sSMC carriers has been performed in individuals harboring
the inv dup(15) sSMC and identified that 82.7% of sperm were
272 AMERICAN JOURNAL OF MEDICAL GENETICS PART Aunisomic, 17% were disomic, and 0.3% were trisomic suggesting
there is a selection against the sSMC during meiosis [Eggermann
et al., 2002]. Even with this selection, spermatogenesis appears to be
significantly affected forunknown reasons.An additional important
consideration is that a number of individuals affected with a
McClintock mechanism-derived sSMC are severely neurocogni-
tively impaired and do not have children, which should be differen-
tiated from the infertility experienced by the patient described here.
Review of Table I shows that unlike other sSMC, those that arise
via the suspected McClintock mechanism appear to not have a
predilection towards involvement of acrocentric chromosomes.
Roughly 40%of all sSMC involve chromosome 15, with our patient
representing the first to be identified with a McClintock mecha-
nism-derived chromosome 15 aberration [http://ssmc-tl.com/
sSMC.html]. Interestingly, other acrocentric chromosomes appear
to be involved, including chromosomes 13 and 22. It is possible that
the chromosomal architecture of acrocentric chromosomes is not
as susceptible to the McClintock mechanism as they are to the
formation of other types of sSMC. The exact mechanism underly-
ing this discrepancy is unknown at this time.
Interestingly, review of Table I also reveals the presence of a
patient with an autosomal dominant Mendelian condition and an
sSMC.Case 8 carried a clinical diagnosis of neurofibromatosis type 1
(NF1) based on the presence of axillary freckling and numerous
pathologically confirmedneurofibromas [Andersen et al., 1990].No
NF 1 features were present in the patient’s parents, seven siblings or
daughter. She was found to have a chromosome 17-derived sSMC
containing chromosomal material from a chromosome 17 intersti-
tial deletion with the breakpoints around 17q11.2 or 17q12. The
gene responsible for neurofibromatosis type 1, NF1, is on chromo-
some 17q12, the suspected breakpoint of the McClintock chromo-
some [Wallace et al., 1990]. Similar to our patient, whose ring
chromosomecontainsat leastpartof theFBN1gene, itwas suspected
that the NF1 allele on the sSMC was either truncated via the ring’s
formation or experienced silencing via its proximity to the centro-
mere [Andersen et al., 1990]. Additional molecular analysis was
never performed to confirm any of these hypotheses.
The genetic counseling for a patient or family harboring an sSMC
can be complex based on the various chromosomal segregation
possibilities and resultant phenotypic consequences. Patients need
to be informed that this is a rare cytogenetic finding and therefore
information is limited. Genetic counseling needs to define an sSMC
andhowchromosome imbalances can result and address the fertility
issues, increased risk for pregnancy losses and the increased risk for
children with genetic conditions, birth defects, and/or intellectual
disability. In addition, reproductive options (assisted reproductive
technologies, donor sperm/egg depending on patient’s gender,
adoption) and genetic testing options need to be discussed. In
individuals with an apparently balanced karyotype due to the
presence of a ring chromosome derived from a chromosomal
deletion, empiric data suggests four possible resultant karyotypes
in future offspring: (i) normal chromosomal constitution; (ii)
inheritance of the deleted chromosome and the ring chromosome
(apparently balanced); (iii) inheritance of only the deleted chromo-
some (monosomic); (iv) inheritance of the ring chromosome and
the normal chromosome (trisomic). There are other unbalanced
karyotypes that could arise due to other abnormal segregations thatwould result in greater imbalances and likely early miscarriage. In
our patient’s case, his abnormal interval also included the Prader–
Willi/Angelman syndrome region of chromosome 15 further com-
plicating the counseling as potential chromosomal segregations also
carried a risk for both of these conditions.
The patient presented here represents the first patient to be
reported with an interstitial deletion of chromosome 15 with a
resultant ring sSMC formed and stabilized by a neocentromere.
The patient carried a clinical diagnosis of Marfan syndrome and it
was determined that at least part of the FBN1 gene was on the
sSMC. It is possible that the FNB1 allele itself or its regulatory
elements were either disrupted through the process of ring forma-
tion or its proximity to the neocentromere resulted in the gene’s
silencing. Thismechanismmay also explain the clinical diagnosis of
NF1 in a patient with a similar karyotypic abnormality [Andersen
et al., 1990]. The abnormal chromosomal constitution was only
identified as part of a work up for infertility, which is known to be
associated with the presence of an sSMC. Our case continues to
support the use of peripheral karyotype analysis in the evaluation of
infertility particularly when a Mendelian condition is present.ACKNOWLEDGMENT
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